Skip to main content
CCFN
OTC Finance

Journey Bank Sells $9.1M Non-Performing Mortgage Portfolio, Incurs $0.7M Pretax Charge

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$60
Mkt Cap
$212.159M
52W Low
$32.5
52W High
$60
Market data snapshot near publication time

Summary

Journey Bank, a subsidiary of Muncy Columbia Financial, sold a portfolio of nonperforming mortgage loans for approximately $9.1 million, resulting in a $0.7 million pretax charge.


Key Events

  • Asset Disposition

    Journey Bank entered into an agreement to sell a portfolio of 82 delinquent, nonperforming, or reperforming residential mortgage loans.

  • Transaction Value

    The purchase price for the loan portfolio was approximately $9.1 million, against an outstanding principal balance of $9.8 million.

  • Financial Impact

    The sale will result in a pretax charge of approximately $0.7 million, to be recognized in the quarter ending March 31, 2026.

  • Balance Sheet Improvement

    This strategic sale removes problematic assets from the balance sheet, improving overall asset quality and reducing future credit risk.


Analysis

Muncy Columbia Financial's subsidiary, Journey Bank, has strategically divested a portfolio of delinquent and nonperforming residential mortgage loans. While the sale results in a modest $0.7 million pretax charge, it significantly cleans up the bank's balance sheet by removing problematic assets. This move enhances asset quality and reduces future risk, which is a positive signal, especially as the company's stock is currently trading near its 52-week high.

At the time of this filing, CCFN was trading at $60.00 on OTC in the Finance sector, with a market capitalization of approximately $212.2M. The 52-week trading range was $32.50 to $60.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CCFN - Latest Insights

CCFN
May 12, 2026, 10:52 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $74.24
Real-time Price: $27.71 info
Change: -$46.53 (-63%) info
Market Cap: $294.065M info
CCFN
May 08, 2026, 11:49 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $74.40
Real-time Price: $27.71 info
Change: -$46.69 (-63%) info
Market Cap: $294.065M info
CCFN
Apr 24, 2026, 11:45 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $73.92
Real-time Price: $27.71 info
Change: -$46.21 (-63%) info
Market Cap: $294.065M info
CCFN
Apr 23, 2026, 10:09 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $74.25
Real-time Price: $27.71 info
Change: -$46.54 (-63%) info
Market Cap: $294.065M info
CCFN
Apr 20, 2026, 11:25 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $68.00
Real-time Price: $27.71 info
Change: -$40.29 (-59%) info
Market Cap: $294.065M info
CCFN
Mar 06, 2026, 2:35 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $61.85
Real-time Price: $27.71 info
Change: -$34.14 (-55%) info
Market Cap: $294.065M info
CCFN
Feb 18, 2026, 3:00 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $60.56
Real-time Price: $27.71 info
Change: -$32.85 (-54%) info
Market Cap: $294.065M info
CCFN
Jan 29, 2026, 2:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $60.00
Real-time Price: $27.71 info
Change: -$32.29 (-54%) info
Market Cap: $294.065M info
CCFN
Jan 21, 2026, 12:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $56.17
Real-time Price: $27.71 info
Change: -$28.46 (-51%) info
Market Cap: $294.065M info